ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Intravenous Immunoglobulin (IVIg) Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-26A15491
Home | Market Reports | Health| Health Conditions
Global and India Intravenous Immunoglobulin IVIg Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Intravenous Immunoglobulin (IVIg) Market Report & Forecast 2023-2029

Code: QYRE-Auto-26A15491
Report
November 2023
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Octapharma AG
Octapharma
CSL Limited
CSL Ltd
Baxter
Grifols S A
Biotest
Kedrion S p A
Hualan Bio
CNBG
Shanghai Raas
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

and India Intravenous Immunoglobulin (IVIg) Market Size

The global Intravenous Immunoglobulin (IVIg) revenue was US$ 10310 million in 2022 and is forecast to a readjusted size of US$ 15470 million by 2029 with a CAGR of 5.9% during the forecast period (2023-2029).

and India Intravenous Immunoglobulin (IVIg) Market

and India Intravenous Immunoglobulin (IVIg) Market

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
In India, the Intravenous Immunoglobulin (IVIg) revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
This report focuses on global and India Intravenous Immunoglobulin (IVIg) market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Intravenous Immunoglobulin (IVIg) will continue to grow rapidly in the future.
Global Intravenous Immunoglobulin (IVIg) Scope and Market Size
Intravenous Immunoglobulin (IVIg) market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Intravenous Immunoglobulin (IVIg) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Intravenous Immunoglobulin (IVIg) market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Intravenous Immunoglobulin (IVIg) Market Report

Report Metric Details
Report Name and India Intravenous Immunoglobulin (IVIg) Market
Forecasted market size in 2029 US$ 15470 million
CAGR 5.9%
Forecasted years 2023 - 2029
Segment by Type
  • IVIg Liquid
  • IVIg Powder
Segment by Application
  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Intravenous Immunoglobulin (IVIg) Market size in 2029?

Ans: The and India Intravenous Immunoglobulin (IVIg) Market size in 2029 will be US$ 15470 million.

What is the market share of major companies in and India Intravenous Immunoglobulin (IVIg) Market?

Ans: Global top four manufacturers hold a share above 65%.

What is the and India Intravenous Immunoglobulin (IVIg) Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Intravenous Immunoglobulin (IVIg) Market report?

Ans: The main players in the and India Intravenous Immunoglobulin (IVIg) Market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang

What are the Application segmentation covered in the and India Intravenous Immunoglobulin (IVIg) Market report?

Ans: The Applications covered in the and India Intravenous Immunoglobulin (IVIg) Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the and India Intravenous Immunoglobulin (IVIg) Market report?

Ans: The Types covered in the and India Intravenous Immunoglobulin (IVIg) Market report are IVIg Liquid, IVIg Powder

1 Study Coverage
1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
1.2 Global Intravenous Immunoglobulin (IVIg) Outlook 2018 VS 2022 VS 2029
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales in US$ Million for the Year 2018-2029
1.2.2 Global Intravenous Immunoglobulin (IVIg) Sales in Volume for the Year 2018-2029
1.3 India Intravenous Immunoglobulin (IVIg) Outlook 2018 VS 2022 VS 2029
1.3.1 India Intravenous Immunoglobulin (IVIg) Sales in US$ Million for the Year 2018-2029
1.3.2 India Intravenous Immunoglobulin (IVIg) Sales in Volume for the Year 2018-2029
1.4 Intravenous Immunoglobulin (IVIg) Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Intravenous Immunoglobulin (IVIg) in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Intravenous Immunoglobulin (IVIg) Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Intravenous Immunoglobulin (IVIg) Market Dynamics
1.5.1 Intravenous Immunoglobulin (IVIg) Industry Trends
1.5.2 Intravenous Immunoglobulin (IVIg) Market Drivers
1.5.3 Intravenous Immunoglobulin (IVIg) Market Challenges
1.5.4 Intravenous Immunoglobulin (IVIg) Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Intravenous Immunoglobulin (IVIg) by Type
2.1 Intravenous Immunoglobulin (IVIg) Market Segment by Type
2.1.1 IVIg Liquid
2.1.2 IVIg Powder
2.2 Global Intravenous Immunoglobulin (IVIg) Market Size by Type
2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Intravenous Immunoglobulin (IVIg) Market Size by Type
2.3.1 India Intravenous Immunoglobulin (IVIg) Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Intravenous Immunoglobulin (IVIg) Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Intravenous Immunoglobulin (IVIg) by Application
3.1 Intravenous Immunoglobulin (IVIg) Market Segment by Application
3.1.1 Immunodeficiency
3.1.2 Autoimmune Disease
3.1.3 Acute Infection
3.2 Global Intravenous Immunoglobulin (IVIg) Market Size by Application
3.2.1 Global Intravenous Immunoglobulin (IVIg) Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Intravenous Immunoglobulin (IVIg) Market Size by Application
3.3.1 India Intravenous Immunoglobulin (IVIg) Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Intravenous Immunoglobulin (IVIg) Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Intravenous Immunoglobulin (IVIg) Competitor Landscape by Company
4.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Company
4.1.1 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Ranked by Revenue (2022)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2018-2023)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2018-2023)
4.1.4 Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2018-2023)
4.2 Global Intravenous Immunoglobulin (IVIg) Concentration Ratio (CR)
4.2.1 Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Intravenous Immunoglobulin (IVIg) in 2022
4.2.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Offered and Application
4.5 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Intravenous Immunoglobulin (IVIg) Market Size by Company
4.7.1 Key Players of Intravenous Immunoglobulin (IVIg) in India, Ranked by Revenue (2022)
4.7.2 India Intravenous Immunoglobulin (IVIg) Revenue by Players (2018-2023)
4.7.3 India Intravenous Immunoglobulin (IVIg) Sales by Players (2018-2023)
5 Global Intravenous Immunoglobulin (IVIg) Market Size by Region
5.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Intravenous Immunoglobulin (IVIg) Market Size in Volume by Region (2018-2029)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales in Volume by Region: 2018-2023
5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales in Volume Forecast by Region (2024-2029)
5.3 Global Intravenous Immunoglobulin (IVIg) Market Size in Value by Region (2018-2029)
5.3.1 Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region: 2018-2023
5.3.2 Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2018-2029
6.2 Americas Intravenous Immunoglobulin (IVIg) Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Intravenous Immunoglobulin (IVIg) Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Intravenous Immunoglobulin (IVIg) Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Intravenous Immunoglobulin (IVIg) Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2018-2029
7.2 EMEA Intravenous Immunoglobulin (IVIg) Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Intravenous Immunoglobulin (IVIg) Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Intravenous Immunoglobulin (IVIg) Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Intravenous Immunoglobulin (IVIg) Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2018-2029
8.2 China Intravenous Immunoglobulin (IVIg) Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Intravenous Immunoglobulin (IVIg) Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2018-2029
9.2 APAC Intravenous Immunoglobulin (IVIg) Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Intravenous Immunoglobulin (IVIg) Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Intravenous Immunoglobulin (IVIg) Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Intravenous Immunoglobulin (IVIg) Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Information
10.1.2 Baxter Description and Business Overview
10.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
10.1.5 Baxter Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Description and Business Overview
10.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
10.2.5 Grifols Recent Development
10.3 CSL
10.3.1 CSL Company Information
10.3.2 CSL Description and Business Overview
10.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered
10.3.5 CSL Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Description and Business Overview
10.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
10.4.5 Octapharma Recent Development
10.5 Biotest
10.5.1 Biotest Company Information
10.5.2 Biotest Description and Business Overview
10.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
10.5.5 Biotest Recent Development
10.6 Kedrion
10.6.1 Kedrion Company Information
10.6.2 Kedrion Description and Business Overview
10.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
10.6.5 Kedrion Recent Development
10.7 Hualan Bio
10.7.1 Hualan Bio Company Information
10.7.2 Hualan Bio Description and Business Overview
10.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
10.7.5 Hualan Bio Recent Development
10.8 CNBG
10.8.1 CNBG Company Information
10.8.2 CNBG Description and Business Overview
10.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
10.8.5 CNBG Recent Development
10.9 Shanghai RAAS
10.9.1 Shanghai RAAS Company Information
10.9.2 Shanghai RAAS Description and Business Overview
10.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
10.9.5 Shanghai RAAS Recent Development
10.10 CBPO
10.10.1 CBPO Company Information
10.10.2 CBPO Description and Business Overview
10.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
10.10.5 CBPO Recent Development
10.11 LFB Group
10.11.1 LFB Group Company Information
10.11.2 LFB Group Description and Business Overview
10.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered
10.11.5 LFB Group Recent Development
10.12 BPL
10.12.1 BPL Company Information
10.12.2 BPL Description and Business Overview
10.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.12.4 BPL Intravenous Immunoglobulin (IVIg) Products Offered
10.12.5 BPL Recent Development
10.13 Sichuan Yuanda Shuyang
10.13.1 Sichuan Yuanda Shuyang Company Information
10.13.2 Sichuan Yuanda Shuyang Description and Business Overview
10.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered
10.13.5 Sichuan Yuanda Shuyang Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
11.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process
11.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
11.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
11.4.2 Intravenous Immunoglobulin (IVIg) Distributors
11.5 Intravenous Immunoglobulin (IVIg) Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Octapharma AG
Octapharma
CSL Limited
CSL Ltd
Baxter
Grifols S A
Biotest
Kedrion S p A
Hualan Bio
CNBG
Shanghai Raas
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
List of Tables
    Table 1. Intravenous Immunoglobulin (IVIg) CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Intravenous Immunoglobulin (IVIg) Market Trends
    Table 3. Intravenous Immunoglobulin (IVIg) Market Drivers
    Table 4. Intravenous Immunoglobulin (IVIg) Market Challenges
    Table 5. Intravenous Immunoglobulin (IVIg) Market Restraints
    Table 6. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer, (K Bottle), 2018-2023
    Table 14. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturer, 2018-2023
    Table 15. Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2018-2023) & (USD/Bottle)
    Table 16. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2022)
    Table 18. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Offered and Application
    Table 20. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Intravenous Immunoglobulin (IVIg) in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Intravenous Immunoglobulin (IVIg) Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Intravenous Immunoglobulin (IVIg) Revenue Share by Players, (2018-2023)
    Table 25. India Intravenous Immunoglobulin (IVIg) Sales by Players, (K Bottle), (2018-2023)
    Table 26. India Intravenous Immunoglobulin (IVIg) Sales Share by Players, (2018-2023)
    Table 27. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Intravenous Immunoglobulin (IVIg) Sales in Volume by Region (2018-2023) & (K Bottle)
    Table 29. Global Intravenous Immunoglobulin (IVIg) Sales in Volume Forecast by Region (2024-2029) & (K Bottle)
    Table 30. Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Intravenous Immunoglobulin (IVIg) Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Intravenous Immunoglobulin (IVIg) Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Intravenous Immunoglobulin (IVIg) Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Intravenous Immunoglobulin (IVIg) Sales in Volume by Country (2018-2023) & (K Bottle)
    Table 36. Americas Intravenous Immunoglobulin (IVIg) Sales in Volume by Country (2024-2029) & (K Bottle)
    Table 37. EMEA Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Intravenous Immunoglobulin (IVIg) Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Intravenous Immunoglobulin (IVIg) Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Intravenous Immunoglobulin (IVIg) Sales in Volume by Country (2018-2023) & (K Bottle)
    Table 41. EMEA Intravenous Immunoglobulin (IVIg) Sales in Volume by Country (2024-2029) & (K Bottle)
    Table 42. APAC Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Intravenous Immunoglobulin (IVIg) Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Intravenous Immunoglobulin (IVIg) Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Intravenous Immunoglobulin (IVIg) Sales in Volume by Country (2018-2023) & (K Bottle)
    Table 46. APAC Intravenous Immunoglobulin (IVIg) Sales in Volume by Country (2024-2029) & (K Bottle)
    Table 47. Baxter Company Information
    Table 48. Baxter Description and Business Overview
    Table 49. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 50. Baxter Intravenous Immunoglobulin (IVIg) Product
    Table 51. Baxter Recent Development
    Table 52. Grifols Company Information
    Table 53. Grifols Description and Business Overview
    Table 54. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 55. Grifols Intravenous Immunoglobulin (IVIg) Product
    Table 56. Grifols Recent Development
    Table 57. CSL Company Information
    Table 58. CSL Description and Business Overview
    Table 59. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 60. CSL Intravenous Immunoglobulin (IVIg) Product
    Table 61. CSL Recent Development
    Table 62. Octapharma Company Information
    Table 63. Octapharma Description and Business Overview
    Table 64. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 65. Octapharma Intravenous Immunoglobulin (IVIg) Product
    Table 66. Octapharma Recent Development
    Table 67. Biotest Company Information
    Table 68. Biotest Description and Business Overview
    Table 69. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 70. Biotest Intravenous Immunoglobulin (IVIg) Product
    Table 71. Biotest Recent Development
    Table 72. Kedrion Company Information
    Table 73. Kedrion Description and Business Overview
    Table 74. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 75. Kedrion Intravenous Immunoglobulin (IVIg) Product
    Table 76. Kedrion Recent Development
    Table 77. Hualan Bio Company Information
    Table 78. Hualan Bio Description and Business Overview
    Table 79. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 80. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
    Table 81. Hualan Bio Recent Development
    Table 82. CNBG Company Information
    Table 83. CNBG Description and Business Overview
    Table 84. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 85. CNBG Intravenous Immunoglobulin (IVIg) Product
    Table 86. CNBG Recent Development
    Table 87. Shanghai RAAS Company Information
    Table 88. Shanghai RAAS Description and Business Overview
    Table 89. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 90. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
    Table 91. Shanghai RAAS Recent Development
    Table 92. CBPO Company Information
    Table 93. CBPO Description and Business Overview
    Table 94. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 95. CBPO Intravenous Immunoglobulin (IVIg) Product
    Table 96. CBPO Recent Development
    Table 97. LFB Group Company Information
    Table 98. LFB Group Description and Business Overview
    Table 99. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 100. LFB Group Intravenous Immunoglobulin (IVIg) Product
    Table 101. LFB Group Recent Development
    Table 102. BPL Company Information
    Table 103. BPL Description and Business Overview
    Table 104. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 105. BPL Intravenous Immunoglobulin (IVIg) Product
    Table 106. BPL Recent Development
    Table 107. Sichuan Yuanda Shuyang Company Information
    Table 108. Sichuan Yuanda Shuyang Description and Business Overview
    Table 109. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2018-2023)
    Table 110. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
    Table 111. Sichuan Yuanda Shuyang Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Intravenous Immunoglobulin (IVIg) Customers List
    Table 115. Intravenous Immunoglobulin (IVIg) Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
    Figure 2. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Size 2018-2029 (US$ Million)
    Figure 4. Global Intravenous Immunoglobulin (IVIg) Sales 2018-2029 (K Bottle)
    Figure 5. India Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Intravenous Immunoglobulin (IVIg) Market Size 2018-2029 (US$ Million)
    Figure 7. India Intravenous Immunoglobulin (IVIg) Sales 2018-2029 (K Bottle)
    Figure 8. India Intravenous Immunoglobulin (IVIg) Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Intravenous Immunoglobulin (IVIg) Market Share in Global, in Volume (K Bottle) 2018-2029
    Figure 10. Intravenous Immunoglobulin (IVIg) Report Years Considered
    Figure 11. Product Picture of IVIg Liquid
    Figure 12. Product Picture of IVIg Powder
    Figure 13. Global Intravenous Immunoglobulin (IVIg) Market Share by Type in 2022 & 2029
    Figure 14. Global Intravenous Immunoglobulin (IVIg) Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type (2018-2029)
    Figure 16. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2029) & (K Bottle)
    Figure 17. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2018-2029)
    Figure 18. Global Intravenous Immunoglobulin (IVIg) Price by Type (2018-2029) & (USD/Bottle)
    Figure 19. India Intravenous Immunoglobulin (IVIg) Market Share by Type in 2022 & 2029
    Figure 20. India Intravenous Immunoglobulin (IVIg) Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 21. India Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type (2018-2029)
    Figure 22. India Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2029) & (K Bottle)
    Figure 23. India Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2018-2029)
    Figure 24. India Intravenous Immunoglobulin (IVIg) Price by Type (2018-2029) & (USD/Bottle)
    Figure 25. Product Picture of Immunodeficiency
    Figure 26. Product Picture of Autoimmune Disease
    Figure 27. Product Picture of Acute Infection
    Figure 28. Global Intravenous Immunoglobulin (IVIg) Market Share by Application in 2022 & 2029
    Figure 29. Global Intravenous Immunoglobulin (IVIg) Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 30. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application (2018-2029)
    Figure 31. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2029) & (K Bottle)
    Figure 32. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2018-2029)
    Figure 33. Global Intravenous Immunoglobulin (IVIg) Price by Application (2018-2029) & (USD/Bottle)
    Figure 34. India Intravenous Immunoglobulin (IVIg) Market Share by Application in 2022 & 2029
    Figure 35. India Intravenous Immunoglobulin (IVIg) Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 36. India Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application (2018-2029)
    Figure 37. India Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2029) & (K Bottle)
    Figure 38. India Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2018-2029)
    Figure 39. India Intravenous Immunoglobulin (IVIg) Price by Application (2018-2029) & (USD/Bottle)
    Figure 40. Americas Intravenous Immunoglobulin (IVIg) Sales in Volume Growth Rate 2018-2029 (K Bottle)
    Figure 41. Americas Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 42. Americas Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2029) & (K Bottle)
    Figure 43. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2018-2029)
    Figure 44. Americas Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2029) & (K Bottle)
    Figure 45. Americas Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2018-2029)
    Figure 46. United States Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Canada Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Mexico Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. EMEA Intravenous Immunoglobulin (IVIg) Sales in Volume Growth Rate 2018-2029 (K Bottle)
    Figure 51. EMEA Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 52. EMEA Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2029) & (K Bottle)
    Figure 53. EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2018-2029)
    Figure 54. EMEA Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2029) & (K Bottle)
    Figure 55. EMEA Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2018-2029)
    Figure 56. Europe Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Middle East Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Africa Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. China Intravenous Immunoglobulin (IVIg) Sales in Volume Growth Rate 2018-2029 (K Bottle)
    Figure 60. China Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 61. China Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2029) & (K Bottle)
    Figure 62. China Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2018-2029)
    Figure 63. China Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2029) & (K Bottle)
    Figure 64. China Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2018-2029)
    Figure 65. APAC Intravenous Immunoglobulin (IVIg) Sales in Volume Growth Rate 2018-2029 (K Bottle)
    Figure 66. APAC Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 67. APAC Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2029) & (K Bottle)
    Figure 68. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2018-2029)
    Figure 69. APAC Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2029) & (K Bottle)
    Figure 70. APAC Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2018-2029)
    Figure 71. Japan Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 72. South Korea Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. China Taiwan Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. India Intravenous Immunoglobulin (IVIg) Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Intravenous Immunoglobulin (IVIg) Value Chain
    Figure 77. Intravenous Immunoglobulin (IVIg) Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions